# Best Novo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/best-novo

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.bestnovo.com
- Latest round: Series A (Nov 2, 2017)
- Investors on record: 2

## About

Based in Beijing, China and established in 2013, Best Novo is a health care company that focuses on heart and cerebral vessel's treatment, providing genetic testing services and medicine instruction. The company has set up nearly 5,000 square meters of professional medical testing laboratories, nearly 7,000 square meters of professional medical equipment and in vitro diagnostic reagent production bases in Beijing, Jiangsu, Hebei and other provinces and cities. The company is recognized as a national high-tech enterprise, a “small giant” enterprise in Beijing specializing in specialties and new technologies, a scientific and technological research and development institution in Beijing, and a pilot unit of intellectual property rights in Beijing. In addition, it has been approved and examined for nearly 100 invention patents and more than 60 utility model patents and software copyrights.

The company’s main business is providing comprehensive genetic testing and counseling services for cardiovascular and cerebrovascular diseases. The company’s self-developed products include a suite of genetic testing services that are used in the field of precision medicine for early diagnosis and personalized treatment of genetic diseases.

The company generates revenue by providing its genetic testing services to hospitals, research institutions, and individuals seeking personalized medical solutions.

## Funding rounds

- Series A, Nov 2, 2017 — Goodhope Financial Service, Innohealth

## Investors

- Goodhope Financial Service (https://capitalatlas.ai/funds/goodhope-financial-service) — Series A
- Innohealth — Series A